Chuanglong He

Find an error

Name: 何创龙; ChuangLong He
Organization: College of Chemistry , China
Department: College of Chemistry, Chemical Engineering and Biotechnology
Title: Researcher/Professor(PhD)

TOPICS

Co-reporter:Liang Chen, Xiaojun Zhou, Wei Nie, Wei Feng, Qianqian Zhang, Weizhong Wang, Yanzhong Zhang, Zhigang Chen, Peng Huang, and Chuanglong He
ACS Applied Materials & Interfaces May 31, 2017 Volume 9(Issue 21) pp:17786-17786
Publication Date(Web):May 9, 2017
DOI:10.1021/acsami.7b04488
The construction of safe and stable theranostics is beneficial to realize simultaneous cancer diagnosis and treatment. In this study, bovine serum albumin–gadolinium (BSA–Gd) complexes and MoS2 nanoflakes (MoS2–Gd–BSA) were successfully married as cancer theranostics for dual-modality magnetic resonance (MR)/photoacoustic (PA) imaging and photothermal therapy (PTT). BSA–Gd complexes were prepared by the biomineralization method and then conjugated with MoS2 nanoflakes via an amide bond. The as-prepared MoS2–Gd–BSA possessed a good photostability and photothermal effect. The cytotoxicity assessment and hemolysis assay suggested the excellent biocompatibility of MoS2–Gd–BSA. Meanwhile, MoS2–Gd–BSA could not only achieve in vivo MR/PA dual-modality imaging of xenograft tumors, but also effectively kill cancer cells in vitro and ablate the xenograft tumors in vivo upon 808 nm laser illumination. The biodistribution and histological evaluations indicated the negligible toxicity of MoS2–Gd–BSA both in vitro and in vivo. Thus, our results substantiated the potential of MoS2–Gd–BSA for cancer theranostics.Keywords: cancer theranostics; magnetic resonance imaging; MoS2 nanoflakes; photoacoustic imaging; photothermal therapy;
Co-reporter:Liang Chen, Yihan Feng, Xiaojun Zhou, Qianqian Zhang, Wei Nie, Weizhong Wang, Yanzhong Zhang, and Chuanglong He
ACS Applied Materials & Interfaces May 24, 2017 Volume 9(Issue 20) pp:17347-17347
Publication Date(Web):May 4, 2017
DOI:10.1021/acsami.7b02657
Developing biodegradable photothermal agent holds great significance for potential clinical translation of photothermal therapy. In the current study, one-pot hydrothermal synthesis of MoS2 nanoflakes with desirable degradation capability was presented. The participation of poly(acrylic acid) (PAA) in hydrothermal process could not only facilitate the modification of polyethylene glycol (PEG), but also bestow degradability to the prepared MoS2 nanoflakes. Moreover, the PEGylated hybrid nanoflakes (MoS2–PPEG) also exhibited excellent stability in various medium and outstanding photothermal properties. Interestingly, MoS2–PPEG behaved distinctly different degradation rate in diverse condition. The rapid degradation of MoS2–PPEG was observed in neutral pH solution, whereas much slower degradation occurred in an acidic tumor microenvironment. Furthermore, data indicated that the major degradation product of MoS2–PPEG was water-soluble Mo-based ion. Meanwhile, the good in vitro biocompatibility of MoS2–PPEG was also confirmed in terms of cytotoxicity and hemolysis. With favorable photothermal performance, MoS2–PPEG can efficiently killing cancer cells in vitro and suppress the tumor growth in vivo. More importantly, the gradual decreasing content of MoS2–PPEG in organs and detectable Mo element in urine of mice suggested that the degradability of MoS2–PPEG might facilitate its excretion to some degree. Hence, the degradable MoS2 nanoflakes prepared by one-pot hydrothermal routine may provide insight for further biomedical applications of inorganic photothermal agent.Keywords: degradable; inorganic; MoS2 nanoflakes; one-pot; photothermal therapy;
Co-reporter:Dejian Li, Wei Nie, Liang Chen, Xiaojun Zhou, Weizhong Wang, Chuanglong He, Baoqing Yu
Journal of Controlled Release 2017 Volume 259(Volume 259) pp:
Publication Date(Web):10 August 2017
DOI:10.1016/j.jconrel.2017.03.076
Co-reporter:Weizong Weng;Wei Nie;Qirong Zhou;Xiaojun Zhou;Liehu Cao;Fang Ji;Jin Cui;Jiacan Su
RSC Advances (2011-Present) 2017 vol. 7(Issue 5) pp:2753-2765
Publication Date(Web):2017/01/04
DOI:10.1039/C6RA26062D
Infected bone defects (IBD) are a challenging problem in orthopedic practice. Biomaterials have attracted attention as a novel approach to overcome this challenge instead of using conventional strategies. Graphene, a two-dimensional carbon allotrope, has been shown to possess multiple advantages, such as osteogenesis-promoting activity, a large surface area for drug delivery, and antibacterial activities. However, these attractive merits have not been entirely explored or introduced for the management of IBD. Herein, a novel approach using a vancomycin-laden, self-assembled, graphene-based material against IBD was developed, and the approach uses a single-stage bone graft instead of multiple procedures. Owing to the π–π bonding with graphene, vancomycin can be promptly delivered in the initial stage, followed by a sustained release, which ensures the rapid elimination of an infection and provides a durable pathogen revival inhibition via the inherent antibacterial activity of graphene. Moreover, the 3D porous structure incorporated with nano-hydroxyapatite (nHA) provided a biomimetic microenvironment favored by cell adhesion and osteogenic differentiation. Further evaluation of this system in an IBD animal model demonstrated prompt control of infection and promotion of bone regeneration. These results revealed the potential of this approach to be an effectual solution for IBD treatment and a new area of graphene application in the future.
Co-reporter:Dejian Li;Wei Nie;Liang Chen;Yingke Miao;Xu Zhang;Fancheng Chen;Bin Yu;Rongguang Ao;Baoqing Yu
RSC Advances (2011-Present) 2017 vol. 7(Issue 13) pp:7973-7982
Publication Date(Web):2017/01/20
DOI:10.1039/C6RA27319J
Nanofiber mats have been widely applied in various biomedical fields such as drug delivery, tissue repair and wound dressing. In this study, the curcumin-loaded mesoporous silica incorporated nanofiber mats were prepared using blend electrospinning of curcumin-loaded mesoporous silica nanoparticles (CCM-MSNs) and polyvinyl pyrrolidone (PVP) for hemostasis. The prepared mats were then evaluated to determine their structure, biocompatibility and antibacterial activity, especially focusing on the hemostatic effect using an in vivo liver injury model. The results showed that CCM-MSN loading ratios less than 8 wt% could be homogeneously dispersed in the PVP electrospun nanofibers. The in vitro studies demonstrated that the hybrid nanofiber mats had no obvious toxic effect on the growth of L929 cells. The hybrid nanofiber mats also exhibited enhanced in vitro antibacterial effects against methicillin-resistant Staphylococcus aureus (MRSA). The antibacterial effect of the hybrid nanofiber mats was further confirmed by in vivo experiments. Moreover, the in vivo hemostasis studies revealed that the hybrid nanofiber mats could rapidly transform into hydrogel when they contact with blood, and then activate the clotting system to stop the wound bleeding. Therefore, the CCM-MSN incorporated PVP nanofiber mats provide a practical possibility for nanofiber-based hemostatic materials with good biocompatibility and high antibacterial activity.
Co-reporter:Kexin Qiu, Bo Chen, Wei Nie, Xiaojun Zhou, Wei Feng, Weizhong Wang, Liang Chen, Xiumei Mo, Youzhen Wei, and Chuanglong He
ACS Applied Materials & Interfaces 2016 Volume 8(Issue 6) pp:4137
Publication Date(Web):January 6, 2016
DOI:10.1021/acsami.5b11879
The incorporation of microcarriers as drug delivery vehicles into polymeric scaffold for bone regeneration has aroused increasing interest. In this study, the aminated mesoporous silica nanoparticles (MSNs-NH2) were prepared and used as microcarriers for dexamethasone (DEX) loading. Poly(l-lactic acid)/poly(ε-caprolactone) (PLLA/PCL) nanofibrous scaffold was fabricated via thermally induced phase separation (TIPS) and served as template, onto which the drug-loaded MSNs-NH2 nanoparticles were deposited by electrophoretic deposition (EPD). The physicochemical and release properties of the prepared scaffolds (DEX@MSNs-NH2/PLLA/PCL) were examined, and their osteogenic activities were also evaluated through in vitro and in vivo studies. The release of DEX from the scaffolds revealed an initial rapid release followed by a slower and sustained one. The in vitro results indicated that the DEX@MSNs-NH2/PLLA/PCL scaffold exhibited good biocompatibility to rat bone marrow-derived mesenchymal stem cells (BMSCs). Also, BMSCs cultured on the DEX@MSNs-NH2/PLLA/PCL scaffold exhibited a higher degree of osteogenic differentiation than those cultured on PLLA/PCL and MSNs-NH2/PLLA/PCL scaffolds, in terms of alkaline phosphatase (ALP) activity, mineralized matrix formation, and osteocalcin (OCN) expression. Furthermore, the in vivo results in a calvarial defect model of Sprague–Dawley (SD) rats demonstrated that the DEX@MSNs-NH2/PLLA/PCL scaffold could significantly promote calvarial defect healing compared with the PLLA/PCL scaffold. Thus, the EPD technique provides a convenient way to incorporate osteogenic agents-containing microcarriers to polymer scaffold, and thus, prepared composite scaffold could be a potential candidate for bone tissue engineering application due to its capacity for delivery of osteogenic agents.Keywords: bone tissue engineering; dexamethasone; electrophoretic deposition; mesoporous silica nanoparticles (MSNs); poly(L-lactic acid)/poly(ε−caprolactone) scaffold
Co-reporter:Yating Jia, Weizhong Wang, Xiaojun Zhou, Wei Nie, Liang Chen and Chuanglong He  
Polymer Chemistry 2016 vol. 7(Issue 14) pp:2553-2564
Publication Date(Web):14 Mar 2016
DOI:10.1039/C5PY01993A
Poly(glycerol sebacate) (PGS) has been explored extensively for tissue engineering applications due to its elastomeric mechanical properties and biocompatibility, but its relatively low mechanical strength and poor hydrophilicity restrict its practical applications in tissue engineering. In this study, we developed new biodegradable elastomeric copolyesters poly(glycerol-co-sebacic acid-co-L-lactic acid-co-polyethylene glycol) (PGSLP) by simultaneously introducing L-lactic acid (LLA) and polyethylene glycol (PEG) into the PGS network. The synthesized copolyesters were well-characterized to evaluate their physicochemical properties, mechanical strength and in vitro degradation properties, and their biocompatibility was also evaluated by a combination of in vivo and in vitro experiments. It is found that the PGSLP exhibited typical elastic properties, and possessed better hydrophilicity, water uptake capacity as well as improved degradation behaviors compared to PGS, which were beneficial for tissue engineering applications. More importantly, the physicochemical properties of PGSLP could be tuned in a wide range by changing the content of LLA and PEG, and their mechanical properties were visibly influenced by the curing conditions such as curing time. Furthermore, the L929 mouse fibroblast cells cultured on the PGSLP exhibited high viability, good spreading and proliferation, and PGSLP implants did not induce obvious inflammatory reaction but promoted neovascularization after subcutaneous implantation in Sprague-Dawley rats for 5 weeks. Hence, the developed PGSLP copolyesters may offer a much better choice of scaffolds than PGS for practical tissue engineering applications.
Co-reporter:Liang Chen, Wei Feng, Xiaojun Zhou, Kexin Qiu, Yingke Miao, Qianqian Zhang, Ming Qin, Lei Li, Yanzhong Zhang and Chuanglong He  
RSC Advances 2016 vol. 6(Issue 16) pp:13040-13049
Publication Date(Web):25 Jan 2016
DOI:10.1039/C5RA27822H
Synergistic therapy, the combination of photothermal therapy and chemotherapy, has been becoming an attractive strategy to circumvent certain drawbacks in current cancer chemotherapy. Herein, a synergistic therapeutic nanoplatform based on novel albumin functionalized flower-like MoS2 spherical nanoparticles was reported. The MoS2 nanoparticles were prepared by using hydrazine hydrate as both reductive agent and structure-directing agent via a facile hydrothermal procedure. Bovine serum albumin (BSA) was subsequently modified onto the surface of MoS2 (MoS2@BSA) to improve the physiological stability and biocompatibility of nanoparticles. The results indicated that the prepared MoS2@BSA hybrid nanoparticles not only possess high photothermal conversion efficiency and physiological stability, but also the ability to effectively load and intelligently release the chemotherapeutic drug doxorubicin hydrochloride (DOX). The in vitro cytotoxicity of MoS2@BSA was tested with murine breast cancer cells (4T1), revealing the excellent biocompatibility of hybrid nanoparticles. Furthermore, the negligible hemolytic activity and efficient cellular uptake of MoS2@BSA was also testified. More importantly, the combination of DOX loading and photothermal treatment with MoS2@BSA in the form of MoS2@BSA–DOX displayed better therapeutic efficacy than single photothermal therapy or chemotherapy. Thus, our results demonstrated that the novel combined therapeutic nanoplatform based on the flower-like MoS2 hybrid nanoparticles could be an attractive candidate for cancer treatments.
Co-reporter:Xiaojun Zhou, Liang Chen, Wei Nie, Weizhong Wang, Ming Qin, Xiumei Mo, Hongsheng Wang, and Chuanglong He
The Journal of Physical Chemistry C 2016 Volume 120(Issue 39) pp:22375-22387
Publication Date(Web):September 15, 2016
DOI:10.1021/acs.jpcc.6b06759
The combination of chemotherapy and gene therapy could induce the enhanced therapeutic efficacy in the cancer therapy. To achieve this goal, a new mesoporous silica nanoparticles (MSNs)-based codelivery system was developed for targeted simultaneous delivery of doxorubicin (DOX) and Bcl-2 small interfering RNA (siRNA) into breast cancer cells. The multifunctional MSNs (MSNs-PPPFA) were prepared by modification of polyethylenimine–polylysine copolymers (PEI-PLL) via the disulfide bonds, to which a targeting ligand folate-linked poly(ethylene glycol) (FA-PEG) was conjugated. The multifunctional MSNs-PPPFA nanocarrier has the ability to encapsulate DOX into the mesoporous channels of MSNs, while simultaneously carrying siRNA via electrostatic interaction between cationic MSNs-PPPFA and anionic siRNA. The resulting MSNs-PPPFA nanoparticles were characterized with various techniques. The drug release results reveal that DOX released from DOX-loaded MSNs-PPPFA are both pH- and redox-responsive, and the results of cell viability and hemolysis assays show that the functional nanocarrier has excellent biocompatibility. Importantly, the folate-conjugated MSNs-PPPFA showed significantly enhanced intracellular uptake in the folate receptor overexpressed MDA-MB-231 breast cancer cells than nontargeted counterparts and thus results in more DOX and siRNA being codelivered into the cells. Furthermore, the delivery of Bcl-2 siRNA obviously downregulate the Bcl-2 protein expression, and thus targeted codelivery of DOX and Bcl-2 siRNA by DOX@MSNs-PPPFA/Bcl-2 siRNA in MDA-MB-231 cells could induce remarkable cell apoptosis as indicated by the results of cell viability and cell apoptosis assays. These results indicate that the constructed DOX@MSNs-PPPFA/Bcl-2 siRNA codelivery system is promising for targeted treatment of breast cancer.
Co-reporter:Liang Chen, Xiaojun Zhou, Wei Nie, Qianqian Zhang, Weizhong Wang, Yanzhong Zhang, and Chuanglong He
ACS Applied Materials & Interfaces 2016 Volume 8(Issue 49) pp:
Publication Date(Web):November 18, 2016
DOI:10.1021/acsami.6b11802
The convenient modification of mesoporous silica nanoparticles (MSN) can provide great opportunities for constructing a new generation of nanocarriers with multiple functions. In the current study, we fabricated a new multifunctional drug delivery system based on MSN capped by gadolinium-based bovine serum albumin complex (BSA-Gd) and hyaluronic acid (HA) via reductive-cleavable disulfide bond. In this multifunctional nanoparticle (MSN-ss-GHA), BSA-Gd component was prepared by biomineralization and acted as both smart gatekeeper and contrast agent for magnetic resonance (MR) imaging, while HA served as the targeted molecule to improve the specific affinity of MSN-ss-GHA toward cancer cells. The successful fabrication of MSN-ss-GHA was demonstrated by a series of physicochemical characterization. The redox-sensitive drug release behavior of doxorubicin hydrochloride (DOX) loaded MSN-ss-GHA (DOX@MSN-ss-GHA) was also verified. Comparatively, the MSN-ss-GHA exhibited excellent biocompatibility and distinctly enhanced cell uptake by 4T1 cells. More importantly, the improved in vitro MR imaging ability of MSN-ss-GHA over that of Gd-DTPA was also confirmed. The results also suggested that the DOX@MSN-ss-GHA could efficiently deliver DOX into 4T1 cells and showed enhanced cytotoxicity as compared to that of nontargeted nanocarrier. The in vivo experiment also demonstrated the negligible toxicity of MSN-ss-GHA and improved antitumor suppression of DOX@MSN-ss-GHA. Thus, this multifunctional MSN-based theranostic agent holds potential for efficient redox-responsive targeting drug delivery and MR imaging.Keywords: cancer theranostics; magnetic resonance imaging; mesoporous silica nanoparticles; redox-responsive; targeted drug delivery;
Co-reporter:Wei Feng, Xiaojun Zhou, Wei Nie, Liang Chen, Kexin Qiu, Yanzhong Zhang, and Chuanglong He
ACS Applied Materials & Interfaces 2015 Volume 7(Issue 7) pp:4354
Publication Date(Web):February 9, 2015
DOI:10.1021/am508837v
Construction of multifunctional nanocomposites as theranostic platforms has received considerable biomedical attention. In this study, a triple-functional theranostic agent based on the cointegration of gold nanorods (Au NRs) and superparamagnetic iron oxide (Fe3O4) into polypyrrole was developed. Such a theranostic agent (referred to as Au/PPY@Fe3O4) not only exhibits strong magnetic property and high near-infrared (NIR) optical absorbance but also produces high contrast for magnetic resonance (MR) and X-ray computed tomography (CT) imaging. Importantly, under the irradiation of the NIR 808 nm laser at the power density of 2 W/cm2 for 10 min, the temperature of the solution containing Au/PPY@Fe3O4 (1.4 mg/mL) increased by about 35 °C. Cell viability assay showed that these nanocomposites had low cytotoxicity. Furthermore, an in vitro photothermal treatment test demonstrates that the cancer cells can be efficiently killed by the photothermal effects of the Au/PPY@Fe3O4 nanocomposites. In summary, this study demonstrates that the highly versatile multifunctional Au/PPY@Fe3O4 nanocomposites have great potential in simultaneous multimodal imaging-guided cancer theranostic applications.Keywords: Au/PPY@Fe3O4 nanocomposites; magnetic resonance imaging (MRI); photothermal therapy; theranostics; X-ray computed tomography (CT)
Co-reporter:Xiaojun Zhou, Wei Feng, Kexin Qiu, Liang Chen, Weizhong Wang, Wei Nie, Xiumei Mo, and Chuanglong He
ACS Applied Materials & Interfaces 2015 Volume 7(Issue 29) pp:15777
Publication Date(Web):July 2, 2015
DOI:10.1021/acsami.5b02636
Bone morphogenetic protein-2 (BMP-2), a growth factor that induces osteoblast differentiation and promotes bone regeneration, has been extensively investigated in bone tissue engineering. The peptides of bioactive domains, corresponding to residues 73–92 of BMP-2 become an alternative to reduce adverse side effects caused by the use of high doses of BMP-2 protein. In this study, BMP-2 peptide functionalized mesoporous silica nanoparticles (MSNs-pep) were synthesized by covalently grafting BMP-2 peptide on the surface of nanoparticles via an aminosilane linker, and dexamethasone (DEX) was then loaded into the channel of MSNs to construct nanoparticulate osteogenic delivery systems (DEX@MSNs-pep). The in vitro cell viability of MSNs-pep was tested with bone mesenchymal stem cells (BMSCs) exposure to different particle concentrations, revealing that the functionalized MSNs had better cytocompatibility than their bare counterparts, and the cellular uptake efficiency of MSNs-pep was remarkably larger than that of bare MSNs. The in vitro results also show that the MSNs-pep promoted osteogenic differentiation of BMSCs in terms of the levels of alkaline phosphatase (ALP) activity, calcium deposition, and expression of bone-related protein. Moreover, the osteogenic differentiation of BMSCs can be further enhanced by incorporating of DEX into MSNs-pep. After intramuscular implantation in rats for 3 weeks, the computed tomography (CT) images and histological examination indicate that this nanoparticulate osteogenic delivery system induces effective osteoblast differentiation and bone regeneration in vivo. Collectively, the BMP-2 peptide and DEX incorporated MSNs can act synergistically to enhance osteogenic differentiation of BMSCs, which have potential applications in bone tissue engineering.Keywords: bone morphogenetic peptide; cellular uptake; dexamethasone; mesoporous silica nanoparticles; osteogenic differentiation;
Co-reporter:Xiaojun Zhou, Liang Chen, Weizhong Wang, Yating Jia, Anni Chang, Xiumei Mo, Hongsheng Wang and Chuanglong He  
RSC Advances 2015 vol. 5(Issue 81) pp:65897-65904
Publication Date(Web):21 Jul 2015
DOI:10.1039/C5RA11830A
Drug delivery via electrospun nanofibers represents a new approach to treat tissue damage resulting from cancer or cancer treatment. In this study, we propose a decomposable nanoparticle-incorporated electrospun mat as carrier for anticancer drugs. The anticancer drug doxorubicin (DOX) was initially loaded into SiO2 nanoparticles (DOX@SiO2), and the prepared DOX-loaded nanoparticles were then introduced into a poly(lactic-co-glycolic acid)/chitosan (PLGA/CS) mixed solution to fabricate drug-loaded composite nanofibers (PLGA/CS/DOX@SiO2) via electrospinning. The prepared nanoparticles and drug-loaded nanofibers were characterized by various methods, and the results indicated that the DOX@SiO2 nanoparticles were dispersively embedded inside PLGA/CS nanofibers. The PLGA/CS/DOX@SiO2 composite nanofibers showed a sustained and controlled drug release profile. Moreover, the DOX released from the composite nanofibers achieved significant antitumor activity, thereby effectively inhibiting the growth of HeLa cells. Thus, the prepared composite nanofibrous mats containing self-decomposable nanocarriers would be potential candidates for cancer treatment.
Co-reporter:Wei Feng, Zhiqi Yin, Weizhong Wang, Liang Chen, Xiaojun Zhou, Kexin Qiu, Jianfeng Zhou, Yanzhong Zhang and Chuanglong He  
RSC Advances 2015 vol. 5(Issue 76) pp:61580-61585
Publication Date(Web):10 Jul 2015
DOI:10.1039/C5RA11525F
In this paper, we present a facile thermally induced phase separation (TIPS) technique for the synthesis of size and morphology controllable poly(L-lactic acid) (PLLA) nanofibrous hollow microspheres (NHMs). The effects of propanetriol (PT) volume, polymer concentration, dropping rate, stirring speed and addition sequence on the physical properties of NHMs including particle size and surface morphology were systematically investigated. The results revealed that the obtained NHMs became more round in shape and more uniform in size with the increase of the PT volume. When the concentration of polymer solution was increased to 4%, the obtained NHMs showed a homogeneous nanofibrous structure, while their size became bigger and more uniform than those of prepared in lower polymer concentrations. The increased dropping rate of PT resulted in the packed nanofibrous structure and decreased microsphere size, whereas the increased stirring speed led to a reduced microsphere size. The uniformity and morphology of microspheres are also strongly influenced by the addition sequence. Furthermore, the in vitro cytotoxicity assay demonstrated that NHMs possess good biocompatibility. As a result, the synthesized NHMs would have significant potential in a variety of biomedical applications such as drug delivery and tissue regeneration.
Co-reporter:Weizhong Wang;Jinwei Hu;Wei Nie;Wei Feng;Kexin Qiu;Xiaojun Zhou;Yu Gao;Guoqing Wang
Journal of Biomedical Materials Research Part A 2015 Volume 103( Issue 5) pp:1784-1797
Publication Date(Web):
DOI:10.1002/jbm.a.35315

Abstract

The success of tissue engineered vascular grafts depends greatly on the synthetic tubular scaffold, which can mimic the architecture, mechanical, and anticoagulation properties of native blood vessels. In this study, small-diameter tubular scaffolds were fabricated with different weight ratios of poly(l-lactic acid) (PLLA) and poly(l-lactide-co-ɛ-caprolactone) (PLCL) by means of thermally induced phase separation technique. To improve the anticoagulation property of materials, heparin was covalently linked to the tubular scaffolds by N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride and N-hydroxysuccinimide coupling chemistry. The as-prepared PLLA/PLCL scaffolds retained microporous nanofibrous structure as observed in the neat PLLA scaffolds, and their structural and mechanical properties can be fine-tuned by changing the ratio of two components. The scaffold containing 60% PLCL content was found to be the most promising scaffold for engineering small-diameter blood vessel in terms of elastic properties and structural integrity. The heparinized scaffolds showed higher hydrophilicity, lower protein adsorption ability, and better in vitro anticoagulation property than their untreated counterparts. Pig iliac endothelial cells seeded on the heparinized scaffold showed good cellular attachment, spreading, proliferation, and phenotypic maintenance. Furthermore, the heparinized scaffolds exhibited neovascularization after subcutaneous implantation into the New Zealand white rabbits for 1 and 2 months. Taken together, the heparinized PLLA/PLCL nanofibrous scaffolds have the great potential for vascular tissue engineering application. © 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 1784–1797, 2015.

Co-reporter:Wei Feng, Wei Nie, Yanhua Cheng, Xiaojun Zhou, Liang Chen, Kexin Qiu, Zhigang Chen, Meifang Zhu, Chuanglong He
Nanomedicine: Nanotechnology, Biology and Medicine 2015 Volume 11(Issue 4) pp:901-912
Publication Date(Web):May 2015
DOI:10.1016/j.nano.2014.12.015
Copper sulfide (CuS) has emerged as a promising photothermal agent. However, its potential toxic effects still remained poorly understood. Herein, CuS nanoplates were synthesized for toxicity assessment. The in vitro study indicated that the cell viability decreased when CuS nanoplate concentration was higher than 100 μg/mL. CuS nanoplates caused apparent toxicity to HUVEC and RAW 264.7 cells. For acute toxicity, maximum tolerated dose and lethal dose 50 were 8.66 and 54.5 mg/kg, respectively. Furthermore, the sub-chronic toxicity test results indicated that there was no obvious effect at tested doses during the test period. The biodistribution study showed that intravenously administrated CuS nanoplates were mainly present in the spleen, liver and lung. Taken together, our results shed light on the rational design of CuS nanomaterials to minimize toxicity, thus providing a useful guideline in selecting CuS as the photothermal agent for cancer therapy.From the Clinical EditorPhotothermal ablation therapy is a promising new treatment modality for cancer. One of the potential photothermal agents is copper sulfide (CuS). In this article, the potential toxic effects of CuS nanoplates were studied. The authors showed that further modification on the design of CuS nanomaterials was needed to minimize toxicity.Copper sulfide (CuS) nanoplates have recently emerged as a new and promising type of photothermal agent for cancer therapy. However, the potential toxic effects of CuS nanoplates still remained poorly understood. Herein, both in vitro and in vivo extensive studies were performed to evaluate the biocompatibility of CuS nanoplates. It is demonstrated that CuS nanoplates have no obvious toxicity. Therefore, our results provide a useful critical guideline in selecting CuS nanoplates for cancer photothermal ablation therapy.
Co-reporter:Chuanglong He, Wei Nie and Wei Feng  
Journal of Materials Chemistry A 2014 vol. 2(Issue 45) pp:7828-7848
Publication Date(Web):22 Sep 2014
DOI:10.1039/C4TB01464B
Biomimetic nanofibers have emerged as promising candidates for drug delivery and tissue engineering applications. In this paper, recent advances on the fabrication and application of biomimetic nanofibers as drug carriers and scaffolding materials are reviewed. First, we delineate the three popular nanofiber fabrication techniques including electrospinning, phase separation and molecular self-assembly, covering the principal materials used for different techniques and surface functionalization strategies for nanofibers. Furthermore, we focus our interest on the nanofiber-based delivery strategies and underlying kinetics for growth factors and other bioactive molecules, following which we summarize the recent advances in the development of these nanofibrous matrices for bone, vascular and neural tissue engineering applications. Finally, research challenges and future trends in the related areas are discussed.
Co-reporter:Wei Feng, Wei Nie, Chuanglong He, Xiaojun Zhou, Liang Chen, Kexin Qiu, Weizhong Wang, and Zhiqi Yin
ACS Applied Materials & Interfaces 2014 Volume 6(Issue 11) pp:8447
Publication Date(Web):April 21, 2014
DOI:10.1021/am501337s
Surface fuctionalization plays a crucial role in developing efficient nanoparticulate drug-delivery systems by improving their therapeutic efficacy and minimizing adverse effects. Here we propose a simple layer-by-layer self-assembly technique capable of constructing mesoporous silica nanoparticles (MSNs) into a pH-responsive drug delivery system with enhanced efficacy and biocompatibility. In this system, biocompatible polyelectrolyte multilayers of alginate/chitosan were assembled on MSN’s surface to achieve pH-responsive nanocarriers. The functionalized MSNs exhibited improved blood compatibility over the bare MSNs in terms of low hemolytic and cytotoxic activity against human red blood cells. As a proof-of-concept, the anticancer drug doxorubicin (DOX) was loaded into nanocarriers to evaluate their use for the pH-responsive drug release both in vitro and in vivo. The DOX release from nanocarriers was pH dependent, and the release rate was much faster at lower pH than that of at higher pH. The in vitro evaluation on HeLa cells showed that the DOX-loaded nanocarriers provided a sustained intracellular DOX release and a prolonged DOX accumulation in the nucleus, thus resulting in a prolonged therapeutic efficacy. In addition, the pharmacokinetic and biodistribution studies in healthy rats showed that DOX-loaded nanocarriers had longer systemic circulation time and slower plasma elimination rate than free DOX. The histological results also revealed that the nanocarriers had good tissue compatibility. Thus, the biocompatible multilayers functionalized MSNs hold the substantial potential to be further developed as effective and safe drug-delivery carriers.Keywords: drug delivery; layer-by-layer assembly; mesoporous silica nanoparticles; pH-responsive; polyelectrolyte multilayer;
Co-reporter:Xiaojun Zhou, Xiao Cheng, Wei Feng, Kexin Qiu, Liang Chen, Wei Nie, Zhiqi Yin, Xiumei Mo, Hongsheng Wang and Chuanglong He  
Dalton Transactions 2014 vol. 43(Issue 31) pp:11834-11842
Publication Date(Web):11 Jun 2014
DOI:10.1039/C4DT01138D
This paper presents a facile method for the fabrication of uniform hollow mesoporous silica nanoparticles (HMSNs) with tunable shell thickness and pore size. In this method, a series of amphiphilic block copolymers of polystyrene-b-poly (acrylic acid) (PS-b-PAA) with different hydrophobic block (PS) lengths were first synthesized via atom transfer radical polymerization (ATRP). The as-synthesized PS-b-PAA and cetyltrimethylammonium bromide (CTAB) were subsequently used as co-templates to fabricate HMSNs. This approach allows the control of shell thickness and pore size distribution of the synthesized HMSNs simply by changing the amounts of PS-b-PAA and CTAB, respectively. In vitro cytotoxicity and hemolysis assays demonstrated that the synthesized HMSNs had a low and shell thickness-dependent cytotoxicity and hemolytic activity. Therefore, these HMSNs have great potential for biomedical applications due to their good biocompatibility and ease of synthesis.
Co-reporter:Mengxia Chen, Wei Feng, Si Lin, Chuanglong He, Yu Gao and Hongsheng Wang  
RSC Advances 2014 vol. 4(Issue 95) pp:53344-53351
Publication Date(Web):07 Oct 2014
DOI:10.1039/C4RA09122A
A co-delivery system with two or more anticancer drugs has been proposed to minimize the dosage of drug and to achieve the synergistic therapeutic effect in cancer therapy. In this study, we present a dual drug delivery system for the co-release of two anticancer drugs doxorubicin hydrochloride (DOX) and hydroxycamptothecin (CPT). To achieve this goal, DOX and CPT were first separately loaded into mesoporous silica and hydroxyapatite nanocarriers, thus, the two prepared drug loaded nanocarriers were then simultaneously incorporated into poly(lactic-co-glycolic acid) (PLGA) nanofibers by electrospinning. The as-prepared medicated nanofibers were well-characterized by different assays, and the results demonstrated that both of the two drug loaded nanocarriers were successfully incorporated into PLGA nanofibers. The in vitro release study indicated that the loaded DOX and CPT exhibited a sustained and controlled release behavior from the dual drug loaded nanofibers. Furthermore, the dual drug loaded nanofibers displayed a superior capacity of inhibiting HeLa cells in vitro to the single drug loaded PLGA nanofibers. Thus, the synthesized dual drug loaded composite nanofibers may find a promising application for cancer therapy.
Co-reporter:Wei Feng, Xiaojun Zhou, Chuanglong He, Kexin Qiu, Wei Nie, Liang Chen, Hongsheng Wang, Xiumei Mo and Yanzhong Zhang  
Journal of Materials Chemistry A 2013 vol. 1(Issue 43) pp:5886-5898
Publication Date(Web):20 Sep 2013
DOI:10.1039/C3TB21193B
Surface functionalization of mesoporous silica nanoparticles (MSNs) has been proposed as an efficient approach to enhance the biocompatibility and efficiency of MSN-based carrier systems. Herein, polyelectrolyte multilayers (PEMs) composed of poly(allylamine hydrochloride) (PAH) and poly(styrene sulfonate) (PSS) were coated onto the MSN surface via a layer-by-layer (LbL) technique, and doxorubicin hydrochloride (DOX) was loaded into the prepared PEM-MSNs, thus constructing potential pH-responsive carrier systems. Extensive studies were performed to evaluate their biocompatibility and efficiency, emphasizing the influences of the layer numbers on the release profiles, cytotoxicity and hemocompatibility. It is demonstrated that PEM layer thickness has an exponential relationship with the number of coated layers, and release profiles of nanoparticles were both pH- and layer thickness-dependent. PEM-MSNs exhibited a very low and layer thickness-dependent cytotoxicity against macrophage cells. They did not induce obvious hemolysis or cause significant platelet aggregation, but also did not activate any coagulation pathways. The cellular uptake of DOX-loaded PEM-MSNs in HeLa cells was remarkably larger than that in L929 cells, thus resulting in a desirable growth-inhibiting effect on cancer cells. DOX-loaded PEM-MSNs exhibited a slower and prolonged DOX accumulation in the nucleus than free DOX. In vivo biodistribution indicated that they induced a sustained drug concentration in blood plasma but lower drug accumulation in the major organs, especially in the heart, compared to free DOX. The histological results also revealed that DOX-loaded PEM-MSNs had lower systemic toxicity than free DOX. Therefore, LbL functionalization of MSNs provides the practical possibility for creating MSN-based carrier systems with low systemic toxicity and high efficiency.
Co-reporter:Kexin Qiu, Chuanglong He, Wei Feng, Weizhong Wang, Xiaojun Zhou, Zhiqi Yin, Liang Chen, Hongsheng Wang and Xiumei Mo  
Journal of Materials Chemistry A 2013 vol. 1(Issue 36) pp:4601-4611
Publication Date(Web):17 Jul 2013
DOI:10.1039/C3TB20636J
A drug-loaded implantable scaffold is a promising alternative for the treatment of a tissue defect after tumor resection. In this study, mesoporous silica nanoparticles (MSNs) were used as carriers to load an anticancer drug – doxorubicin hydrochloride (DOX), and the DOX-loaded MSNs (DOX@MSNs) were subsequently incorporated into poly(L-lactic acid) (PLLA) nanofibers via electrospinning, resulting in a new drug-loaded nanofibrous scaffold (PLLA/DOX@MSNs). The as-prepared composite nanofibrous scaffold was characterized by various techniques. In vitro release profiles of DOX from PLLA/DOX@MSNs composite nanofibers were examined and the in vitro antitumor efficacy against HeLa cells was also evaluated. The results showed that DOX-loaded MSNs were successfully incorporated into composite nanofibers with different MSN (or DOX) contents. Among them, the PLLA/1.0% DOX@10% MSN nanofibers exhibited good particle distribution and improved thermal stability. More importantly, they possessed high DOX-loading capacities due to which the drug can be released in a sustained and prolonged manner, and therefore higher in vitro antitumor efficacy than their MSNs-free counterparts. Thus, the prepared PLLA/MSNs composite nanofibrous mats are highly promising as local implantable scaffolds for potential postsurgical cancer treatment.
Co-reporter:Chuanglong He, Fan Zhang, Lijun Cao, Wei Feng, Kexin Qiu, Yanzhong Zhang, Hongsheng Wang, Xiumei Mo and Jinwu Wang  
Journal of Materials Chemistry A 2012 vol. 22(Issue 5) pp:2111-2119
Publication Date(Web):14 Dec 2011
DOI:10.1039/C1JM14631A
In bone tissue engineering, rapid mineralization of polymeric scaffolds is of particular importance in protecting the encapsulated therapeutic drugs or growth factors from loss and degradation. Here, we present a simple and rapid approach to the fabrication of mineralized porous scaffolds for bone tissue engineering. In this approach, three-dimensional (3-D) porous gelatin scaffolds were firstly fabricated by freeze-drying followed by an electrodeposition process for mineralization. We show that a high-quality apatite coating on the gelatin scaffold could be achieved within a couple of hours by electrodeposition. Increasing the deposition voltage or electrolyte temperature favored to the formation of large amounts of apatite coatings with compositions dominated by the hydroxyapatite crystals, whereas the presence of ultrasonic field facilitated the production of homogeneous apatite coatings. Moreover, biological assays indicated that the mineralized scaffolds exhibited better support for the proliferation and osteoblastic differentiation of MC3T3-E1 cells over a neat gelatin scaffold, especially for the case of mineralized scaffolds by electrodeposition at 60 °C. Therefore, the method developed would be highly desired for the rapid mineralization of polymer scaffolds in which biological molecules were loaded for functional bone tissue engineering applications.
Co-reporter:Chuanglong He;Wei Feng;Lijun Cao;Linpeng Fan
Journal of Biomedical Materials Research Part A 2011 Volume 99A( Issue 4) pp:
Publication Date(Web):
DOI:10.1002/jbm.a.33235

Abstract

The radiation crosslinked poly(L-lactide) (PLLA) electrospun nanofibers have been developed with improved thermal stability and mechanical properties. Trially isocyanurate (TAIC) were added into PLLA solution at different weight ratios (1, 3, and 5%) and electrospun into nanofibrous mats, the mats were then irradiated by gamma ray at different radiation doses (5, 10, and 25 kGy) to crosslink the PLLA chains. Their surface morphology, thermal properties, mechanical properties, and biodegradation properties were investigated and compared before and after gamma irradiation. Furthermore, the in vitro biocompatibilities were also evaluated by using mouse L929 fibroblasts. The results indicated that the efficient crosslinking networks can be generated when the TAIC content is higher than 3%. The thermal stability and tensile mechanical properties were significantly increased at higher irradiation dose of 10 and 25 kGy. However, radiation dose at 25 kGy have an adverse effect on the thermal stability of crosslinked samples due to thermal degradation induced by irradiation, the crosslinked samples irradiated at 10 kGy exhibited the best enzymatic degradation. The in vitro results also revealed that the crosslinked PLLA/TAIC composite nanofibers did not induce cytotoxic effects and are suitable for cell growth. Therefore, the crosslinked PLLA nanofibers are one of the promising materials for future tissue engineering applications. © 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A:, 2011.

Co-reporter:Chuanglong He;Xiaohong Xu;Fan Zhang;Lijun Cao;Wei Feng;Hongsheng Wang;Xiumei Mo
Journal of Biomedical Materials Research Part A 2011 Volume 97A( Issue 3) pp:339-347
Publication Date(Web):
DOI:10.1002/jbm.a.33067

Abstract

Coelectrospinning of native proteins and elastic synthetic polymers is an attractive technique to fabricate hybrid fibrous scaffolds that combine the bioactivity and mechanical features of each material component. In this study, hybrid fibrous scaffolds composed of synthetic P(LLA-CL) elastomeric and naturally derived fibrinogen protein were fabricated and characterized for their bioactive and physiochemical properties. Fiber diameters of hybrid scaffolds increased with increasing P(LLA-CL) content, and the shape of fibers changed from cylindrical shape on pure polymer scaffolds to flat structure on hybrid scaffolds. Characterizations of ATR-FTIR, XRD, and thermal properties indicated that the hybrid scaffolds contain two different phases, one composed of pure fibrinogen and the other corresponding to a mixture of fibrinogen and P(LLA-CL), and no obvious chemical reaction takes place between two components. The hybrid fibrous scaffolds showed tailorable degradation rates than pure P(LLA-CL) and higher mechanical properties than pure fibrinogen, and both tensile strength and breaking strain increased with increasing P(LLA-CL) content. In Vitro studies revealed that L929 cells on hybrid scaffolds achieved relatively higher level of cell attachment after 12 h of culture and significant increased cell proliferation rate after 7 days of culture, when compared with pure fibrinogen and P(LLA-CL) scaffolds, and the cells exhibited a spreading polygonal shape on the hybrid fibrous surfaces compared to a round shape on surfaces of pure polymer scaffolds. Therefore, the fibrinogen/P(LLA-CL) hybrid fibrous scaffolds possess the combined benefits of each individual component, which make it capable as scaffolds for soft tissue reconstruction. © 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A:, 2011.

Co-reporter:Yuanqin Zhu, Haihua Chen and Chuanglong He
Polymer Journal 2011 43(3) pp:258-264
Publication Date(Web):December 22, 2010
DOI:10.1038/pj.2010.129
A new class of aryl trifluorovinyl ether monomers were designed and synthesized, and novel fluorinated polymers containing perfluorocyclobutane and 1H-1,2,3-triazole units were prepared from these monomers. These polymers were characterized by nuclear magnetic resonance spectroscopy, thermo-gravimetric analysis and differential scanning calorimetry. The temperatures of 5% weight loss of the polymers under nitrogen were up to ~290 °C, and the glass transition temperatures of the polymers were in the range of 79–110 °C. These new polymers showed good solubility in common organic solvents such as dimethyl sulfoxide and N,N-dimethylacetamide. In addition, the proton conductivity of the polymers was measured under anhydrous conditions using impedance spectroscopy, and a maximum conductivity of 2.85 μS cm−1 was obtained at 200 °C.
Co-reporter:Yuanqin Zhu;Haihua Chen
Journal of Polymer Research 2011 Volume 18( Issue 6) pp:1409-1416
Publication Date(Web):2011 November
DOI:10.1007/s10965-010-9545-7
A new class of aryl trifluorovinyl ether monomers containing phosphonated oligo(ethylene oxide) units were designed and synthesized. Novel fluorinated polymers containing perfluorocyclobutane and phosphonic acid moieties were prepared from these monomers via the thermal cyclopolymerization and hydrolysis reaction. The structures of these monomers and polymers were characterized by nuclear magnetic resonance spectroscopy and fourier transform spectroscopy. The thermal properties of these polymers were evaluated with differential scanning calorimetry and thermo-gravimetric analysis. The 5% weight loss of these polymers was in range of 258–270 °C in nitrogen, but no glass transition temperatures were detected. The polymers showed good solubility in organic solvents such as dimethyl sulfoxide and N,N-dimethylacetamide. In addition, the basic membrane properties of the membranes such as water uptake and proton conductivity were also measured at room temperature. The membranes exhibited high water uptake (up to 44.7%) due to the high level of phosphonation content. The proton conductivities of the membranes under 100% relative humidity were in the range of 0.032–0.068 S/cm, which entitled them as candidates for proton exchange membranes.
Co-reporter:Su Yan;Li Xiaoqiang;Liu Shuiping;Wang Hongsheng;He Chuanglong
Journal of Applied Polymer Science 2010 Volume 117( Issue 1) pp:542-547
Publication Date(Web):
DOI:10.1002/app.30973

Abstract

Poly(L-lactide acid)-blend-gelatin (PLLA-gelatin) nanofibers were successfully fabricated by means of electrospinning. The different material components characterizing the properties of electrospun PLLA/G nanofibers were measured and the effect of PLLA weight ratios on such properties as morphologies, physical and chemical structure and mechanical profiles were analyzed. It was found that the fibers diameter increases and the ultimate tension-stress enhances with increased PLLA weight ratio. The analysis of X-ray diffractometry, differential scanning calorimetry, and Fourier-transform infrared spectra demonstrated that the resultant nanofibers from electrospinning of PLLA-gelatin solution are simple blends of these two components. © 2010 Wiley Periodicals, Inc. J Appl Polym Sci, 2010

Co-reporter:Chuang-Long He;Zheng-Ming Huang;Xiao-Jian Han
Journal of Biomedical Materials Research Part A 2009 Volume 89A( Issue 1) pp:80-95
Publication Date(Web):
DOI:10.1002/jbm.a.32004

Abstract

In this work, drug-loaded fibers and threads were successfully fabricated by combining electrospinning with aligned fibers collection. Two different electrospinning processes, that is, blend and coaxial electrospinning, to incorporate a model drug tetracycline hydrochloride (TCH) into poly(L-lactic acid) (PLLA) fibers have been used and compared with each other. The resulting composite ultrafine fibers and threads were characterized through scanning electron microscopy, transmission electron microscopy, Fourier transform infrared spectroscopy, X-ray diffraction, differential scanning calorimetry, and tensile testing. It has been shown that average diameters of the fibers made from the same polymer concentration depended on the processing method. The blend TCH/PLLA fibers showed the smallest fiber diameter, whereas neat PLLA fibers and core-shell TCH-PLLA fibers showed a larger proximal average diameter. Higher rotating speed of a wheel collector is helpful for obtaining better-aligned fibers. Both the polymer and the drug in the electrospun fibers have poor crystalline property. In vitro release study indicated that threads made from the core-shell fibers could suppress the initial burst release and provide a sustained drug release useful for the release of growth factor or other therapeutic drugs. On the other hand, the threads from the blend fibers produced a large initial burst release that may be used to prevent bacteria infection. A combination of these results suggests that electrospinning technique provides a novel way to fabricate medical agents-loaded fibrous threads for tissue suturing and tissue regeneration applications. © 2008 Wiley Periodicals, Inc. J Biomed Mater Res, 2009

Co-reporter:Wei Nie, Cheng Peng, Xiaojun Zhou, Liang Chen, Weizhong Wang, Yanzhong Zhang, Peter X. Ma, Chuanglong He
Carbon (May 2017) Volume 116() pp:
Publication Date(Web):May 2017
DOI:10.1016/j.carbon.2017.02.013
Three-dimension (3D) porous reduced graphene oxide (RGO) scaffold has attracted increasing attention in bone tissue engineering due to its favorable osteoinductivity. In this paper, a 3D porous RGO composite was prepared from graphene oxide (GO) and nano-hydroxyapatite (nHA) via self-assembly, thus constructing biomimetic scaffold for bone defect reparation. Detailed studies were performed to evaluate its structure, cellular responses, biocompatibility and in vivo bone repair efficiency, emphasizing the influences of the composite on in vivo bone cell growth and mineralization. The as-prepared scaffold was found to significantly enhance the proliferation, alkaline phosphatase activity (ALP) and osteogenic gene expression of rat bone mesenchymal stem cells (rBMSCs). Further in vivo experiment demonstrated that the circular calvarial defects with 4 mm diameter in rabbit were successfully healed by 20% nHA incorporated RGO (nHA@RGO) porous scaffold after 6 weeks implanting, which was visibly quicker than the RGO one. The computed tomography (CT) and histological analysis showed the improved collagen deposition, cell proliferation and new bone formation occurred in the 20% nHA@RGO treated group. These results indicated that the as-prepared porous scaffold has a promising capacity to stimulate mineralization and promote the in vivo defect healing.
Co-reporter:Xiaojun Zhou, Xiao Cheng, Wei Feng, Kexin Qiu, Liang Chen, Wei Nie, Zhiqi Yin, Xiumei Mo, Hongsheng Wang and Chuanglong He
Dalton Transactions 2014 - vol. 43(Issue 31) pp:NaN11842-11842
Publication Date(Web):2014/06/11
DOI:10.1039/C4DT01138D
This paper presents a facile method for the fabrication of uniform hollow mesoporous silica nanoparticles (HMSNs) with tunable shell thickness and pore size. In this method, a series of amphiphilic block copolymers of polystyrene-b-poly (acrylic acid) (PS-b-PAA) with different hydrophobic block (PS) lengths were first synthesized via atom transfer radical polymerization (ATRP). The as-synthesized PS-b-PAA and cetyltrimethylammonium bromide (CTAB) were subsequently used as co-templates to fabricate HMSNs. This approach allows the control of shell thickness and pore size distribution of the synthesized HMSNs simply by changing the amounts of PS-b-PAA and CTAB, respectively. In vitro cytotoxicity and hemolysis assays demonstrated that the synthesized HMSNs had a low and shell thickness-dependent cytotoxicity and hemolytic activity. Therefore, these HMSNs have great potential for biomedical applications due to their good biocompatibility and ease of synthesis.
Co-reporter:Chuanglong He, Wei Nie and Wei Feng
Journal of Materials Chemistry A 2014 - vol. 2(Issue 45) pp:NaN7848-7848
Publication Date(Web):2014/09/22
DOI:10.1039/C4TB01464B
Biomimetic nanofibers have emerged as promising candidates for drug delivery and tissue engineering applications. In this paper, recent advances on the fabrication and application of biomimetic nanofibers as drug carriers and scaffolding materials are reviewed. First, we delineate the three popular nanofiber fabrication techniques including electrospinning, phase separation and molecular self-assembly, covering the principal materials used for different techniques and surface functionalization strategies for nanofibers. Furthermore, we focus our interest on the nanofiber-based delivery strategies and underlying kinetics for growth factors and other bioactive molecules, following which we summarize the recent advances in the development of these nanofibrous matrices for bone, vascular and neural tissue engineering applications. Finally, research challenges and future trends in the related areas are discussed.
Co-reporter:Kexin Qiu, Chuanglong He, Wei Feng, Weizhong Wang, Xiaojun Zhou, Zhiqi Yin, Liang Chen, Hongsheng Wang and Xiumei Mo
Journal of Materials Chemistry A 2013 - vol. 1(Issue 36) pp:NaN4611-4611
Publication Date(Web):2013/07/17
DOI:10.1039/C3TB20636J
A drug-loaded implantable scaffold is a promising alternative for the treatment of a tissue defect after tumor resection. In this study, mesoporous silica nanoparticles (MSNs) were used as carriers to load an anticancer drug – doxorubicin hydrochloride (DOX), and the DOX-loaded MSNs (DOX@MSNs) were subsequently incorporated into poly(L-lactic acid) (PLLA) nanofibers via electrospinning, resulting in a new drug-loaded nanofibrous scaffold (PLLA/DOX@MSNs). The as-prepared composite nanofibrous scaffold was characterized by various techniques. In vitro release profiles of DOX from PLLA/DOX@MSNs composite nanofibers were examined and the in vitro antitumor efficacy against HeLa cells was also evaluated. The results showed that DOX-loaded MSNs were successfully incorporated into composite nanofibers with different MSN (or DOX) contents. Among them, the PLLA/1.0% DOX@10% MSN nanofibers exhibited good particle distribution and improved thermal stability. More importantly, they possessed high DOX-loading capacities due to which the drug can be released in a sustained and prolonged manner, and therefore higher in vitro antitumor efficacy than their MSNs-free counterparts. Thus, the prepared PLLA/MSNs composite nanofibrous mats are highly promising as local implantable scaffolds for potential postsurgical cancer treatment.
Co-reporter:Chuanglong He, Fan Zhang, Lijun Cao, Wei Feng, Kexin Qiu, Yanzhong Zhang, Hongsheng Wang, Xiumei Mo and Jinwu Wang
Journal of Materials Chemistry A 2012 - vol. 22(Issue 5) pp:NaN2119-2119
Publication Date(Web):2011/12/14
DOI:10.1039/C1JM14631A
In bone tissue engineering, rapid mineralization of polymeric scaffolds is of particular importance in protecting the encapsulated therapeutic drugs or growth factors from loss and degradation. Here, we present a simple and rapid approach to the fabrication of mineralized porous scaffolds for bone tissue engineering. In this approach, three-dimensional (3-D) porous gelatin scaffolds were firstly fabricated by freeze-drying followed by an electrodeposition process for mineralization. We show that a high-quality apatite coating on the gelatin scaffold could be achieved within a couple of hours by electrodeposition. Increasing the deposition voltage or electrolyte temperature favored to the formation of large amounts of apatite coatings with compositions dominated by the hydroxyapatite crystals, whereas the presence of ultrasonic field facilitated the production of homogeneous apatite coatings. Moreover, biological assays indicated that the mineralized scaffolds exhibited better support for the proliferation and osteoblastic differentiation of MC3T3-E1 cells over a neat gelatin scaffold, especially for the case of mineralized scaffolds by electrodeposition at 60 °C. Therefore, the method developed would be highly desired for the rapid mineralization of polymer scaffolds in which biological molecules were loaded for functional bone tissue engineering applications.
Co-reporter:Wei Feng, Xiaojun Zhou, Chuanglong He, Kexin Qiu, Wei Nie, Liang Chen, Hongsheng Wang, Xiumei Mo and Yanzhong Zhang
Journal of Materials Chemistry A 2013 - vol. 1(Issue 43) pp:NaN5898-5898
Publication Date(Web):2013/09/20
DOI:10.1039/C3TB21193B
Surface functionalization of mesoporous silica nanoparticles (MSNs) has been proposed as an efficient approach to enhance the biocompatibility and efficiency of MSN-based carrier systems. Herein, polyelectrolyte multilayers (PEMs) composed of poly(allylamine hydrochloride) (PAH) and poly(styrene sulfonate) (PSS) were coated onto the MSN surface via a layer-by-layer (LbL) technique, and doxorubicin hydrochloride (DOX) was loaded into the prepared PEM-MSNs, thus constructing potential pH-responsive carrier systems. Extensive studies were performed to evaluate their biocompatibility and efficiency, emphasizing the influences of the layer numbers on the release profiles, cytotoxicity and hemocompatibility. It is demonstrated that PEM layer thickness has an exponential relationship with the number of coated layers, and release profiles of nanoparticles were both pH- and layer thickness-dependent. PEM-MSNs exhibited a very low and layer thickness-dependent cytotoxicity against macrophage cells. They did not induce obvious hemolysis or cause significant platelet aggregation, but also did not activate any coagulation pathways. The cellular uptake of DOX-loaded PEM-MSNs in HeLa cells was remarkably larger than that in L929 cells, thus resulting in a desirable growth-inhibiting effect on cancer cells. DOX-loaded PEM-MSNs exhibited a slower and prolonged DOX accumulation in the nucleus than free DOX. In vivo biodistribution indicated that they induced a sustained drug concentration in blood plasma but lower drug accumulation in the major organs, especially in the heart, compared to free DOX. The histological results also revealed that DOX-loaded PEM-MSNs had lower systemic toxicity than free DOX. Therefore, LbL functionalization of MSNs provides the practical possibility for creating MSN-based carrier systems with low systemic toxicity and high efficiency.
Phenol, 4-[[4-(heptadecafluorooctyl)phenyl]azo]-
3-(2-Pyridyldithio)propanoic Acid
Poly[oxy(1-oxo-1,6-hexanediyl)]
Nitric acid,gadolinium(3+) salt (3:1)
Pyridine, 2,2'-dithiobis-
TOSYL-PROPARGYL-TRIETHYLENE GLYCOL
3,6,9,12-Tetraoxapentadec-14-yn-1-ol, 4-methylbenzenesulfonate
Phosphonic acid, [2-(2-bromoethoxy)ethyl]-, diethyl ester